The First Step to Cure Cancer

More sensitive diagnosis leads to faster treatment.
More precise data brings more effective treatment.

We provide sensitive diagnosis and precise results to
support more patients with efficient precision medicine.

ADPS™
Oncogene Mutation Test

ADPS™ Oncogene Mutation Test

PRODUCTS

ADPS™ EGFR Mutation Test Kitarrow_forwardcheck ADPS™ BRAF Mutation Test Kit v1arrow_forwardcheck ADPS™ BRAF Mutation Test Kit v2arrow_forwardcheck ADPS™ KRAS Mutation Test Kit arrow_forwardcheck ADPS™ KRAS G12C Mutation Test Kitarrow_forwardcheck ADPS™ PIK3CA Mutation Test Kitarrow_forwardcheck ADPS™ ESR1 Mutation Test Kitarrow_forwardcheck ADPS™ TERT Promoter Mutation Test Kit arrow_forwardcheck ADPS™ JAK2 V617F Mutation Test Kit arrow_forwardcheck ADPS™ EML4-ALK Gene Fusion Detection Kitarrow_forwardcheck ADPS™ ROS1 Gene Fusion Detection Kitarrow_forwardcheck

Efficient management throughout
the full cycle of cancer

ADPS™
Cancer Panel

Up to LoD
0.01%
Massive
Multiplex
Available for
both liquid and tissue samples
TAT
3h

Now that We've Achieved
the Current Best Sensitivity Possible, What's Next?

We have developed massive multiplex technology
that can diagnose multiple cancer genes at once with high sensitivity.

Digital ADPS, which overcomes the limitations of AS-PCR,
diagnoses dozens of cancer genes with a detection sensitivity of up to 0.01%.

The ADPS™ Cancer Panel, based on Digital ADPS technology,
detects numerous actionable markers at once with high sensitivity.

With a single diagnostic method,
Digital ADPS enables the most efficient management of cancer from early diagnosis to recurrence monitoring.

The RUO Products are Coming Soon.

Launch Plan for
ADPS Cancer Panel

ADPS™ Non-Small Cell Lung Cancer Panel (RUO, Upcoming Release)
ADPS™ Pancreatic Cancer Panel (RUO, Upcoming Release)
ADPS™ Thyroid Cancer Panel Under Development
ADPS™ Melanoma Panel Under Development
ADPS™ Breast Cancer Panel Under Development
Learn More about Digital ADPS arrow_forward

Get ADPS for your diagnosis

Customized Assay Development

LDT commercialization through ADPS adoption
CDx development
of targeted anti-cancer agents
ODM with ADPS adoption

Do you have a sensitivity issue? Consider collaborating with us.
With ADPS technology, you can achieve tenfold greater precision.
We quickly and accurately develop high-quality oncology tests.

Learn More about ADPS arrow_forward Inquiry about Assay Development arrow_forward